Free tool
FAERS Monitor: Vyleesi (Autoinjector)
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 210557 or its brand name (Vyleesi (Autoinjector), Bremelanotide Acetate). Reports on generic versions are filed under their own applications.
Reports
1,150
Serious
35
3% of reports
Hospitalization
6
Death reported
1
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea494
- drug ineffective237
- headache170
- vomiting127
- off label use122
- illness88
- flushing83
- adverse drug reaction65
- dizziness51
- feeling abnormal50
- fatigue48
- malaise43
- condition aggravated40
- cough38
- pain34
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2019 | 40 |
| 2020 | 50 |
| 2021 | 18 |
| 2022 | 45 |
| 2023 | 150 |
| 2024 | 155 |
| 2025 | 341 |
| 2026 | 351 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,009 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| illnessSignal | 88 | 15.6 | 12.8 | 1,196 |
| flushingSignal | 83 | 14.9 | 12.1 | 1,070 |
| adverse drug reactionSignal | 65 | 13.2 | 10.5 | 726 |
| nauseaSignal | 494 | 11.4 | 10.7 | 4,868 |
| headacheSignal | 170 | 5.0 | 4.3 | 550 |
| vomitingSignal | 127 | 4.9 | 4.2 | 404 |
| feeling abnormalSignal | 50 | 3.8 | 2.9 | 102 |
| drug ineffectiveSignal | 237 | 3.3 | 2.9 | 400 |
| off label useSignal | 122 | 2.5 | 2.2 | 118 |
| coughSignal | 38 | 2.5 | 1.8 | 32 |
| condition aggravatedSignal | 40 | 2.4 | 1.8 | 32 |
| dizziness | 51 | 1.9 | 1.4 | 20 |
| malaise | 43 | 1.8 | 1.3 | 15 |
| fatigue | 48 | 1.1 | 0.9 | 1 |
| pain | 34 | 1.0 | 0.7 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.